Epidermal growth factor receptor (EGFR) as a prognostic marker: An immunohistochemical study on 315 consecutive breast carcinoma patients, J. Pak. Med. Assoc, vol.52, pp.104-114, 2002. ,
Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function, Int. J. Cancer, vol.29, pp.741-749, 1997. ,
The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer, Oncogene, vol.14, pp.561-568, 1997. ,
Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin, Hum. Gene Ther, vol.7, pp.275-282, 1996. ,
Tumour marker measurements in the diagnosis and monitoring of breast cancer, Cancer Treat. Rev, vol.26, pp.91-102, 2000. ,
Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: Potential role in metastasis, Clin. Exp. Metastasis, vol.19, pp.339-345, 2002. ,
The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: A bioinformatics assessment, Genome Res, vol.13, pp.2265-2270, 2003. ,
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis, Br. J. Cancer, vol.81, pp.1002-1008, 1999. ,
Identification and immunohistochemical characterization of a mucin-like glycoprotein expressed in early stage breast carcinoma, Tumour Biol, vol.23, pp.263-278, 2002. ,
Targeting gene therapy to cancer: A review, Oncol. Res, vol.9, pp.313-325, 1997. ,
Subtractive hybridization, a technique for extraction of DNA sequences distinguishing two closely related genomes: critical analysis, Genet. Anal, vol.13, pp.49-58, 1996. ,
Tumor angiogenesis in node-negative breast carcinomas-Relationship with epidermal growth factor receptor, estrogen receptor, and survival, Breast Cancer Res. Treat, vol.29, pp.109-116, 1994. ,
Immunotoxin therapy of cancer, Oncology, vol.7, pp.69-86, 1993. ,
Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery, Gene Ther, vol.10, pp.1519-1527, 2003. ,
Biochemistry and immunohistochemistry of fluid proteins of the breast in gross cystic disease, Diseases of the Breast. C.D. Haagensen, pp.474-500, 1986. ,
Prognostic factors in breast cancer: Current and new predictors of metastasis, J. Mammary Gland Biol. Neoplasia, vol.6, pp.375-392, 2001. ,
The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer, Cancer, vol.45, 1980. ,
Transcriptional complementarity in breast cancer: Application to detection of circulating tumor cells, Mol. Diagn, vol.6, pp.79-91, 2001. ,
Structure and inducible regulation of the human c-erb B2/neu promoter, J. Biol. Chem, vol.265, pp.4389-4393, 1990. ,
Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment, Breast Cancer Res, vol.3, pp.395-398, 2001. ,
The biology of erbB-2/ neu/HER-2 and its role in cancer, Biochim. Biophys. Acta, vol.1198, pp.165-184, 1994. ,
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma, Cancer, vol.85, pp.1284-1292, 1999. ,
The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review on 5232 patients, Endocr. Rev, vol.13, pp.3-17, 1992. ,
Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data, J. Mol. Diagn, vol.6, pp.90-95, 2004. ,
Enhanced gene delivery to HER-2-overexpressing breast cancer cells by modified immunolipoplexes conjugated with the anti-HER-2 antibody, J. Biomed. Sci, vol.10, pp.337-344, 2003. ,
Mammaglobin, a potential marker of breast cancer nodal metastasis, J. Pathol, vol.189, pp.28-33, 1999. ,
DNA microarrays: Their use and misuse, Microcirculation, vol.9, pp.13-22, 2002. ,
Prostate-specific antigen (PSA/hK3): A further player in the field of breast cancer diagnostics?, Breast Cancer Res, vol.3, pp.238-243, 2001. ,
O-Glycans, pp.537-549, 1999. ,
Progesterone and estrogen receptors as prognostic variables in breast cancer, Cancer Res, vol.43, pp.2985-2990, 1983. ,
ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients, J. Immunoassay Immunochem, vol.23, pp.293-305, 2002. ,
Identification of a novel breastand salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium, Cancer Res, vol.62, pp.2736-2740, 2002. ,
Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: Correlation with steroid receptor status, Cancer Res, vol.47, pp.4160-4164, 1987. ,
The prolactin-inducible protein (PIP/GCDFP-15) gene: Cloning, structure and regulation, Mol. Cell. Endocrinol, vol.80, pp.165-175, 1991. ,
Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer, Cancer Res, vol.59, pp.5464-5470, 1999. ,
Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure, J. Steroid Biochem. Mol. Biol, vol.37, pp.811-814, 1990. ,
HER-2 and choice of adjuvant chemotherapy in breast cancer, Semin. Oncol, vol.28, pp.332-335, 2001. ,
Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression, J. Clin. Oncol, vol.17, pp.2180-2189, 1999. ,
, , 1998.
, HER-2/neu as a predictive marker of response to breast cancer therapy, Breast Cancer Res. Treat, vol.52, pp.65-77
Effect of vitamin D analog (1alpha hydroxy D5) immunoconjugated to Her-2 antibody on breast cancer, Int. J. Cancer, vol.108, pp.922-999, 2004. ,
Identification of genes preferentially expressed in mammary epithelial cells of Copenhagen rat using subtractive hybridization and microarrays, Carcinogenesis, vol.24, pp.1593-1599, 2003. ,
The Her-2/neu gene and protein in breast cancer 2003: Biomarker and target of therapy, Oncologist, vol.8, pp.307-325, 2003. ,
Model for breast cancer survival: Relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis, Cancer Res, vol.48, pp.5565-5569, 1988. ,
Prolactin-inducible proteins in human breast cancer cells, J. Biol. Chem, vol.260, pp.11307-11313, 1985. ,
Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival, Br. J. Cancer, vol.88, pp.574-578, 2003. ,
Circulating tumor markers in breast cancer: accepted utilities and novel prospects, Breast Cancer Res. Treat, vol.52, pp.239-259, 1998. ,
Detection of mammaglobin expressing cells in blood of breast cancer patients, Cancer Lett, vol.158, pp.171-178, 2000. ,
MUC1 and cancer, Biochim. Biophys. Acta, vol.1455, pp.301-313, 1999. ,
Serial analysis of gene expression, Science, vol.270, pp.484-487, 1995. ,
Human MUC1 mucin: A multifaceted glycoprotein, Int. J. Biol. Markers, vol.15, pp.343-356, 2000. ,
Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer, Cancer Res, vol.56, pp.860-865, 1996. ,
Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers, Br. J. Cancer, vol.90, pp.1531-1537, 2004. ,
Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirustransduced human hematopoietic cells, Proc. Natl. Acad. Sci. USA, vol.96, pp.9654-9659, 1999. ,
Efficacy of post-operative adjuvant therapy for stage IIIa breast cancer: Futraful vs futrafultamoxifen for ER-positive patients and futraful vs futrafuladriamycin for ERnegative breast cancer, Breast Cancer, vol.4, pp.103-113, 1997. ,
Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA, J. Clin. Oncol, vol.17, pp.2015-2019, 1999. ,
Negative autoregulation of the neu gene is mediated by a novel enhancer, Mol. Cell. Biol, vol.12, pp.2739-2748, 1992. ,
Estrogen receptor status of breast cancer: A marker of different stages of tumor or different entities of the disease?, Med. Hypotheses, vol.49, pp.69-75, 1997. ,
Diagnostic value of a second generation CA 15-3 antibody to detect adenocarcinoma in body cavity effusions, Cancer, vol.90, pp.230-234, 2000. ,